Targeting IL-2: an unexpected effect in treating immunological diseases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics
Link
http://www.nature.com/articles/s41392-017-0002-5.pdf
Reference82 articles.
1. Sakaguchi, S. et al. Regulatory T cells and immune tolerance. Cell 133, 775–87 (2008).
2. Lan, Q. et al. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J. Mol. Cell. Biol. 4, 22–8 (2012).
3. Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345–52 (2005).
4. Piccirillo, C. A. & Shevach, E. M. Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16, 81–8 (2004).
5. Zheng, S. G. et al. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J. Immunol. 169, 4183–9 (2002).
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery;Advanced Drug Delivery Reviews;2024-03
2. Translator IL2RA contributes to poor prognosis in kidney clear cell carcinoma by affecting the early stage of lymphocyte activation;2024-01-29
3. Emerging Strategies for Immunotherapy of Solid Tumors Using Lipid‐Based Nanoparticles;Advanced Science;2023-12-06
4. The implication of interleukin-2 on the expression of CD56bright, CD56dim, and interferon-γ in patients with systemic lupus erythematosus;F1000Research;2023-11-28
5. A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease;Translational Neurodegeneration;2023-11-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3